Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

Market Cap	7.18B
Revenue (ttm)	2.14B
Net Income (ttm)	489.89M
Shares Out	234.33M
EPS (ttm)	2.09
PE Ratio	14.66
Forward PE	13.04
Dividend	1.00 (3.24%)
Ex-Dividend Date	Sep 27, 2024

Volume	4,393,713
Average Volume	7,504,800
Open	30.42
Previous Close	30.85
Day's Range	30.42 - 31.49
52-Week Range	23.61 - 37.08
Beta	-0.07
RSI	56.26
Earnings Date	Apr 24, 2025

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salt powder, montmorillonite powder, zithromycin granules, rifaximin dry suspension, and dithiothreitol succinate capsules. In addition, it offers infor...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 1,763
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000915

Financial Performance

In 2023, Shandong Wit Dyne Health's revenue was 2.48 billion, an increase of 6.11% compared to the previous year's 2.34 billion. Earnings were 585.26 million, an increase of 11.08%.